MDLinxRare Lipid Disorders in the Real World: Improving Recognition in Clinical Practice

Rare lipid disorders are genetic conditions present from birth that profoundly impair lipid clearance and can lead to premature atherosclerotic cardiovascular disease or, in some cases, serious noncardiac complications. Although uncommon, these disorders remain underrecognized in routine cardiology practice, where persistent or extreme lipid abnormalities may be attributed to lifestyle or secondary causes alone.

This is a clinical recognition and awareness overview, not a prevalence study or treatment guideline. The emphasis is on identifying patterns that should prompt further evaluation rather than on population-level risk estimates.

Clinical Considerations

• Rare lipid disorders span both high‑lipid syndromes (such as homozygous familial hypercholesterolemia [HoFH]) and low‑lipid syndromes that disrupt lipid transport.
• HoFH is caused by pathogenic variants affecting LDL‑cholesterol clearance and is associated with early plaque buildup, aortic valve disease, and premature myocardial infarction or stroke.
• Diagnosis of HoFH relies on extreme LDL‑C elevations, physical findings, family history, and confirmatory genetic testing when available.
• Low‑lipid disorders, including abetalipoproteinemia, hypobetalipoproteinemia, Tangier disease, and chylomicron retention disease, may present with very low LDL or HDL levels and can cause neurological, visual, hepatic, and growth complications if untreated.
• Initial detection often occurs through a routine fasting lipid panel, with further workup focused on excluding secondary causes before genetic evaluation.

Clinical Practice Impact

• Recognition: Persistently extreme lipid levels—either very high or abnormally low—should prompt consideration of rare inherited disorders rather than reflexive escalation or de‑escalation of standard therapy.
• ASCVD prevention: Early identification of high‑lipid genetic disorders may allow access to specialized therapies and reduce the risk of catastrophic early cardiovascular events.
• Beyond ASCVD: Untreated low‑lipid disorders can lead to severe neurologic, ocular, and developmental complications, underscoring the importance of diagnosis even in the absence of overt cardiovascular disease.
• Team‑based care: Genetic counseling, advanced lipid testing, and specialty referral are often required to confirm diagnosis and guide management.

More in Lipid Health